This educational activity consists of recorded presentations from Advances in the Management of Oncology Patients held in Orlando,Florida on April 6-8, 2011.
As more and more individuals with cancer are prescribed oral chemotherapy, understanding why some patients are unable to take their medications as intended is vitally important. This presentation will identify reasons for oral chemotherapy medication noncompliance and its impact on patient outcomes.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Discuss compliance issues related to oral chemotherapy and how compliance impacts outcomes
2. State the most appropriate clinical indications and diagnoses for oral chemotherapy

Faculty
Joan Lucca, RN, MSN, NP-C, AOCN 
Research Nurse
Thoracic Cancer Treatment Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Disclosures
Please click here to view disclosures and activity planning information.

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Begin by clicking Take Course and viewing the CE Info; then follow the prompts at the bottom of the screen. At the end of the activity you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.
To receive credit, you must pass the Post-Activity Assessment with a score of at least 70% and complete the evaluation form. Responses will be reported in aggregate form from all participants in related educational activities. Thank you for your cooperation.

Sponsored By
This activity is sponsored by OptumHealth Education.

Commercial Support
This activity is supported by Allos Therapeutics, Amgen, Eisai, Novartis Oncology, Shire, Cephalon Oncology, genzyme, Millennium, Novartis, sanofi aventis, National Marrow Donor Program, The Children's Hospital of Philadelphia, and Purdue.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.